Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arum Kim

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Cancer Letters|December 27, 2014
AZD6244 inhibits cisplatin-induced ERK1/2 activation and potentiates cisplatin-associated cytotoxicity in K-ras G12D preclinical modelsEun Young Kim, Arum Kim, Se Kyu Kim, et al.
Cancer Biology & Therapy|June 17, 2020
Clinical implication and usefulness of de novo EGFR T790M mutation in lung adenocarcinoma with EGFR-tyrosine kinase inhibitor sensitizing mutationSang Hoon Lee, Eun Young Kim, Arum Kim, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 4, 2016
Apocynin inhibits Toll-like receptor-4-mediated activation of NF-κB by suppressing the Akt and mTOR pathwaysYoon Jeong Nam, Arum Kim, Dong Suep Sohn, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2017
MYC expression correlates with PD-L1 expression in non-small cell lung cancerEun Young Kim, Arum Kim, Se Kyu Kim, et al.
Journal of Palliative Medicine|March 27, 2019
Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York StateArum Kim, Christopher N Kaufmann, Roxanne Ko, et al.
BMC Cancer|December 8, 2018
Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinomaEun Young Kim, Arum Kim, Gaeun Lee, et al.
BMC Cancer|July 7, 2017
Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancerEun Young Kim, Ji Ye Jung, Arum Kim, et al.
Journal of Cancer|October 22, 2019
Tumor clonal status predicts clinical outcomes of lung adenocarcinoma with EGFR-TKI sensitizing mutationEun Young Kim, Sang Hoon Lee, Arum Kim, et al.
Neoplasia (New York, N.Y.)|March 21, 2017
ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung CancerEun Young Kim, Ji Ye Jung, Arum Kim, et al.
European Journal of Pharmacology|September 20, 2017
K<sub>ATP</sub> channel block inhibits the Toll-like receptor 2-mediated stimulation of NF-κB by suppressing the activation of Akt, mTOR, JNK and p38-MAPKYoon Jeong Nam, Arum Kim, Min Sung Lee, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Cancer Letters|December 27, 2014
AZD6244 inhibits cisplatin-induced ERK1/2 activation and potentiates cisplatin-associated cytotoxicity in K-ras G12D preclinical modelsEun Young Kim, Arum Kim, Se Kyu Kim, et al.
Cancer Biology & Therapy|June 17, 2020
Clinical implication and usefulness of de novo EGFR T790M mutation in lung adenocarcinoma with EGFR-tyrosine kinase inhibitor sensitizing mutationSang Hoon Lee, Eun Young Kim, Arum Kim, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 4, 2016
Apocynin inhibits Toll-like receptor-4-mediated activation of NF-κB by suppressing the Akt and mTOR pathwaysYoon Jeong Nam, Arum Kim, Dong Suep Sohn, et al.
Lung Cancer (Amsterdam, Netherlands)|July 6, 2017
MYC expression correlates with PD-L1 expression in non-small cell lung cancerEun Young Kim, Arum Kim, Se Kyu Kim, et al.
Journal of Palliative Medicine|March 27, 2019
Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York StateArum Kim, Christopher N Kaufmann, Roxanne Ko, et al.
BMC Cancer|December 8, 2018
Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinomaEun Young Kim, Arum Kim, Gaeun Lee, et al.
BMC Cancer|July 7, 2017
Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancerEun Young Kim, Ji Ye Jung, Arum Kim, et al.
Journal of Cancer|October 22, 2019
Tumor clonal status predicts clinical outcomes of lung adenocarcinoma with EGFR-TKI sensitizing mutationEun Young Kim, Sang Hoon Lee, Arum Kim, et al.
Neoplasia (New York, N.Y.)|March 21, 2017
ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung CancerEun Young Kim, Ji Ye Jung, Arum Kim, et al.
European Journal of Pharmacology|September 20, 2017
K<sub>ATP</sub> channel block inhibits the Toll-like receptor 2-mediated stimulation of NF-κB by suppressing the activation of Akt, mTOR, JNK and p38-MAPKYoon Jeong Nam, Arum Kim, Min Sung Lee, et al.
Pageof 5